CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment. (Q52858079)
Jump to navigation
Jump to search
scientific article published in March 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment. |
scientific article published in March 2005 |
Statements
CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment. (English)
1 reference
Roger G Owen
1 reference
Peter Hillmen
1 reference
1 March 2005
1 reference
5
1 reference
4
1 reference
278-281
1 reference